AptaBio Therapeutics Market Cap

AptaBio Therapeutics has a market cap or net worth of 270.16 billion as of July 18, 2025. Its market cap has increased by 84.97% in one year.

Market Cap

270.16B

Enterprise Value

253.20B

Revenue

3.11B

Ranking

n/a

PE Ratio

n/a

Stock Price

9,480.00

Market Cap Chart

Since June 12, 2019, AptaBio Therapeutics's market cap has decreased from 423.30B to 270.16B, a decrease of -36.18%. That is a compound annual growth rate of -7.09%.

Market Cap History

Date	Market Cap	% Change
Jul 18, 2025	270.16B	57.77%
Dec 30, 2024	171.23B	-15.15%
Dec 28, 2023	201.80B	-15.02%
Dec 29, 2022	237.48B	-71.24%
Dec 30, 2021	825.71B	46.50%
Dec 30, 2020	563.64B	49.70%
Dec 30, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	74.80T
Celltrion	39.82T
ALTEOGEN	26.19T
Yuhan	9,866.54B
SK Biopharmaceuticals	8,066.26B
HLB Co., Ltd.	6,939.04B
Peptron	6,861.07B
PharmaResearch	5,890.93B

Market Cap Rankings